The loss of blood–brain barrier P-gp in AD is well-documented: data from several studies show that P-gp protein expression levels are significantly reduced at the blood–brain barrier in AD patients [14, 15, 17, 18, 22]. This evidence concerns the gene PGP and Alzheimer disease.